Drug Pipeline

Pivekimab Sunirine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07306832
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves…		 Recruitment opened
2026-06-03 NCT07306832
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves…		 Trial sites expanded: 0 -> 5 locations
2026-06-03 NCT07306832
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves…		 date change Completion pushed: 2028-04 -> 2030-03
Active Studies by Phase
Phase 2/3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07581002 A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV)… Acute Myeloid Leukemia Not Yet Recruiting
Phase 1
NCT07306832 A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves… Acute Myeloid Leukemia Recruiting
NCT06034470 Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of… Acute Myeloid Leukemia Active, Not Recruiting
Sponsors Running Pivekimab Sunirine Trials
AbbVie (2) Fred Hutchinson Cancer Center (1)
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (3) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1)
Get alerts when Pivekimab Sunirine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free